Zimmer Biomet
-
Biologics
HippoFi Announces Strategic Alliance to Lead Spinal Biologics Innovation
IRVINE, CA., September 6, 2023 / OrthoSpineNews / – HippoFi, Inc. (OTCPK: ORHB) proudly announces a partnership with global medical…
Read More » -
Top Stories
Zimmer Biomet Announces Key Updates to Company’s Executive Leadership Team
Wilfred van Zuilen Promoted to Group President, EMEA Mark Bezjak Promoted to President of the Americas Chief Science, Technology and Innovation Officer Nitin…
Read More » -
Top Stories
Zimmer Biomet Announces Leadership Transition
Chief Operating Officer Ivan Tornos Appointed President and CEO; Elected to the Board of Directors Chief Financial Officer Suketu (Suky) Upadhyay’s Role Expands…
Read More » -
Financial
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2023 Financial Results
WARSAW, Ind., July 5, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference…
Read More » -
Financial
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2023
WARSAW, Ind., May 15, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Recon
Zimmer Biomet Announces Acquisition of OSSIS
SINGAPORE, May 1, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it…
Read More » -
Financial
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2023
WARSAW, Ind., March 8, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Financial
Zimmer Biomet Announces Fourth Quarter and Full-Year 2022 Financial Results
Fourth quarter net sales from continuing operations of $1.825 billion increased 2.7% and 8.3% on a constant currency1 basisFourth quarter diluted loss per…
Read More » -
Financial
Zimmer Biomet to Acquire Embody, Inc.
Deal Strengthens Zimmer Biomet’s Growing Sports Medicine Portfolio and Supports Continued Company Transformation WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ — Zimmer Biomet…
Read More » -
Financial
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2022
WARSAW, Ind., Dec. 15, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Recon
Zimmer Biomet Expands Persona® Knee System Portfolio with FDA Clearance of Persona® OsseoTi® Keel Tibia for Cementless Knee Replacement
New Porous Iteration of Anatomic Keeled Tibia Designed to Deliver Stable Initial and Biological Fixation Together with the Clinically Proven Benefits of…
Read More » -
Recon
Zimmer Biomet Announces One-Year Data from mymobility® Clinical Study at 2022 AAHKS Annual Meeting
One-Year Results Reinforce Interim Findings: mymobility Remote Care Management Platform on Apple Watch and iPhone Yielded Similar Outcomes as Traditional Care…
Read More » -
Financial
Zimmer Biomet Announces Third Quarter 2022 Financial Results
Third quarter net sales from continuing operations of $1.670 billion decreased 0.9% and increased 5.0% on a constant currency1 basisThird quarter diluted earnings…
Read More » -
Regulatory
Zimmer Biomet Receives FDA Clearance for Identity™ Shoulder System for Shoulder Replacement
WARSAW, Ind., Sept. 20, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Recon
Zimmer Biomet and Surgical Planning Associates Announce Exclusive Multi-Year Co-Marketing Agreement for HipInsight™ Mixed Reality System for Total Hip Replacement
WARSAW, Ind., Sept. 1, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More »